0001127602-23-006515.txt : 20230222
0001127602-23-006515.hdr.sgml : 20230222
20230222165836
ACCESSION NUMBER: 0001127602-23-006515
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230218
FILED AS OF DATE: 20230222
DATE AS OF CHANGE: 20230222
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: LANDINE MICHAEL J
CENTRAL INDEX KEY: 0001235600
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35299
FILM NUMBER: 23654277
MAIL ADDRESS:
STREET 1: 88 SIDNEY ST
CITY: CAMBRIDGE
STATE: MA
ZIP: 021394136
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Alkermes plc.
CENTRAL INDEX KEY: 0001520262
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 981007018
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: CONNAUGHT HOUSE
STREET 2: 1 BURLINGTON ROAD
CITY: DUBLIN 4
STATE: L2
ZIP: 00000
BUSINESS PHONE: 00-353-1-772-8000
MAIL ADDRESS:
STREET 1: CONNAUGHT HOUSE
STREET 2: 1 BURLINGTON ROAD
CITY: DUBLIN 4
STATE: L2
ZIP: 00000
FORMER COMPANY:
FORMER CONFORMED NAME: ANTLER SCIENCE TWO PLC
DATE OF NAME CHANGE: 20110804
FORMER COMPANY:
FORMER CONFORMED NAME: Antler Science Two Ltd
DATE OF NAME CHANGE: 20110509
4
1
form4.xml
PRIMARY DOCUMENT
X0306
4
2023-02-18
0001520262
Alkermes plc.
ALKS
0001235600
LANDINE MICHAEL J
852 WINTER ST.
WALTHAM
MA
02451
1
SVP, Corp Dev., Alkermes, Inc.
Ordinary Shares
2023-02-18
4
M
0
4361
A
236667
D
Ordinary Shares
2023-02-18
4
F
0
2065
28.07
D
234602
D
Ordinary Shares
2023-02-20
4
M
0
5354
A
239956
D
Ordinary Shares
2023-02-20
4
F
0
2378
28.07
D
237578
D
Ordinary Shares
2023-02-20
4
A
0
11770
A
249348
D
Ordinary Shares
2023-02-20
4
F
0
5226
28.07
D
244122
D
Ordinary Shares
2023-02-21
4
M
0
5825
A
249947
D
Ordinary Shares
2023-02-21
4
F
0
2587
27.77
D
247360
D
Restricted Stock Unit Award
2023-02-18
4
M
0
4361
D
Ordinary Shares
4361
13084
D
Restricted Stock Unit Award
2023-02-20
4
M
0
5354
D
Ordinary Shares
5354
5354
D
Restricted Stock Unit Award
2023-02-21
4
M
0
5825
D
Ordinary Shares
5825
0
D
Each restricted stock unit represents a contingent right to receive one ordinary share.
These ordinary shares were acquired by the reporting person as a result of the vesting of performance-vesting restricted stock unit awards granted to the reporting person on February 20, 2020 with a three-year performance period that ended on December 31, 2022 (the "2020 PRSUs"). The vesting of this portion of the 2020 PRSUs was triggered by the determination of achievement of certain pre-specified performance goals and application of a total shareholder return modifier and represents the final vesting event under the 2020 PRSUs.
Shares subject to the restricted stock unit award vest in four equal annual installments, commencing on 2/18/2023.
Shares subject to the restricted stock unit award vest in four equal annual installments, commencing on 2/20/2021.
This award is fully vested in accordance with its terms.
/s/ Shantale Greenson, attorney-in-fact for Michael J. Landine
2023-02-22